Opinions+
Perspectives on issues affecting biopharma and health care.
Most Read
A 10-point plan for sustaining the biopharma industrial base for a more secure nation
Bringing clarity and consistency to CMS’s hospital price transparency rule will be a win for all
Viruses, variants, and the business of health care: Preparing for another wave now and the years ahead
Human-centered design can boost clinical trial recruitment, retention
Stifling biopharma mergers would kill the innovation economy that generates new therapies
‘Induced proximity’ is why I am optimistic about treating undruggable diseases
The pharma industry needs to measure patient experience from the patients’ perspectives
All Coverage
advertisement
